Stock GUBRA GUBRA A/S
Add to a list
To use this feature you must be a member
Log inSign up

All News Gubra A/S

Equities

GUBRA

DK0062266474

Market Closed - Nasdaq Copenhagen
Other stock markets
 10:59:37 2024-05-13 am EDT 		5-day change 1st Jan Change
305 DKK -9.76% Intraday chart for Gubra A/S -1.29% +144.00%
Apr. 17 Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss CI
Mar. 29 Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024. CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gubra Unveils UCN2 as Novel Anti-Obesity Drug Candidate for Healthy Weight Loss
CI
Certain Shares of Gubra A/S are subject to a Lock-Up Agreement Ending on 29-MAR-2024.
CI
Gubra Concludes the Research Agreement with Silence Therapeutics plc
CI
Gubra and Boehringer Ingelheim Sign 4Th Partnership, Expanding Their Successful Obesity Treatment Discovery Collaboration
CI
Gubra A/S Announces First Subject Dosed in Phase 1 Clinical Trial of Amylin Agonist for the Treatment of Obesity
CI
Gubra A/S Announces Board Appointments
CI
Gubra Raises Earnings Guidance for Full-Year 2023
CI
Denmark's Gubra Opens First US Office Under Expansion Strategy
MT
Gubra A/S Opens Its First US Office in Boston
CI
Gubra Seeks UK Regulatory Approval to Begin Human Trial for Anti-Obesity Drug
MT
Gubra A/S Submits Clinical Trial Application for First-In-Human Amylin Trial
CI
Tranche Update on Gubra A/S's Equity Buyback Plan announced on June 30, 2023.
CI
Gubra Announces Termination of Collaboration with Bayer AG
CI
Gubra A/S Raises Financial Guidance for Full-Year 2023
CI
Gubra A/S commences an Equity Buyback Plan for 1,180,424 shares, under the authorization approved on March 16, 2023.
CI
Gubra A/S acquired Minigut Aps for DKK 5.96 million.
CI
Gubra A/S Announces Updates to Its Pipeline
CI
Gubra A/S and Boehringer Ingelheim Share Phase 1 Results for BI 1820237
CI
Gubra A/S Provides Revenue Guidance for the Year 2023
CI
Danish Biotech Gubra's IPO Overallotment Option Partly Exercised
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GUBRA Stock
  4. News Gubra A/S
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW